“…Moreover, to explore the entire epilepsy spectrum and according to their seizure frequency and treatment response, PwE were divided into four groups: A) cases responding to treatment with ≤ 1 seizure per year; B) cases responding to treatment with 2–5 seizure per year; C) cases with drug-resistant epilepsy with ≤ 4 seizures per month; D) cases with drug-resistant epilepsy with 5–10 seizures per month. Finally, eligible PwE underwent several self-report questionnaires regarding therapeutic compliance (Morisky Scale) [ 10 ], mood (Generalized Anxiety Disorder – GAD-7, Patient Health Questionnaire – PHQ9, Neurological Disorder Depression – NDDI-E) [ [11] , [12] , [13] ], stress (Impact of Events Scale-Revised – IES-R, Perceived Stress Scale – PSS-10) [ 14 , 15 ], and sleep (Epworth Sleepinees Scale – ESS, Insomnia Severity Index – ISI) [ 16 , 17 ], during quarantine period. PwE were subjected to standardized telephonic or via telemedicine interview and each questionnaire was self-administered.…”